Huatai (06886) will publicly issue short-term corporate bonds (fourth series) to professional investors in 2025 with a fixed coupon rate of 1.64%.
Huatai Securities (06886) releases announcement, according to "Huatai Securities Co., Ltd.s 2025 strategy for professional investors...
Huatai (06886) announced that according to the "Announcement on the Public Issuance of Short-term Corporate Bonds (Fourth Tranche) of Huatai Co., Ltd. for Professional Investors in 2025", the term of the short-term corporate bonds (Fourth Tranche) issued by Huatai Co., Ltd. for professional investors in 2025 (hereinafter referred to as "this Tranche") is 1 year, with a coupon rate quotation range of 1.2% - 2.2%. The coupon rate of this Tranche of bonds is negotiated within the coupon rate quotation range based on the results of the offline rate inquiry by the issuer and the lead underwriter.
On July 21, 2025, the issuer and lead underwriter conducted a coupon rate inquiry for professional institutional investors offline. Based on the results of the coupon rate inquiry from professional institutional investors offline, after unanimous agreement between the issuer and lead underwriter, the final coupon rate for this Tranche of bonds was determined to be 1.64%.
Related Articles

The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.

Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).

CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.
The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.

Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).

CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.

RECOMMEND

Total Investment of 1.2 Trillion Yuan: Yarlung Zangbo Hydropower Project Commences, Creating Investment Opportunities in Water Conservancy, Power Grid, and Cement Sectors
21/07/2025

Another Major Order Secured for Humanoid Robots, Setting a Global Record
21/07/2025

Seven Ministries Jointly Release 11 Measures to Encourage Foreign-Invested Enterprises to Reinvest in China
21/07/2025